Subject's Experience with 4-AcO-DiPT: A Sensual and Energetic Exploration


Table of Contents


  1. Introduction
  2. Background Information
    • Subject's Psychedelic Experience History
    • Influence of Hormone Replacement Therapy
  3. Experimental Setup
    • Dosage and Preparations
    • Tolerance and Potential Confounds
  4. Timeline of the Experience
    • Initial Effects
    • Physical Sensations and Sedation
    • Peak Effects and Sensory Enhancement
  5. Conclusion



1. Introduction


This report details a subjective experience with the psychedelic substance 4-AcO-DiPT, focusing on its effects on the body, mind, and sensory perception. The individual conducting the experiment, referred to as "The Subject," has an extensive background with psychedelics, particularly substituted tryptamines. This experience is analyzed with respect to dose, setting, and the influence of ongoing hormone replacement therapy (HRT), which the subject believes may influence the nature of the psychedelic experience.


2. Background Information


Subject's Psychedelic Experience History


The Subject has an extensive background in psychedelic substances, particularly with substituted tryptamines. Over six years, she has explored a wide range of compounds, including 4-AcO-DMT, 4-AcO-MET, 4-AcO-MiPT, and 5-MeO-MiPT. Although there are some gaps in her experience (e.g., 4-AcO-DET, 5-MeO-DiPT), her broad history with these substances informs her approach to each new experiment. Prior to this experiment with 4-AcO-DiPT, the Subject had conducted independent research, particularly using a primer found on Erowid, which helped inform her expectations of the experience.


Influence of Hormone Replacement Therapy


The Subject has been undergoing female hormone replacement therapy (HRT) for 6-7 months at the time of the experiment. She notes a shift in the nature of her psychedelic experiences since beginning HRT, with a greater emphasis on physical, sensual, and embodied sensations rather than abstract or visual experiences. She is unsure of how these changes will continue to evolve after completing the transition process but observes that they remain as profound as her past psychedelic experiences. This alteration in experience may impact the effects of the substances tested.


3. Experimental Setup


Dosage and Preparations


The substance used in this experiment was 4-AcO-DiPT (Fumarate), taken orally in a 36 mg dose via a gel capsule. The Subject had not consumed any other hallucinogens for at least 4-5 weeks prior, ensuring that tolerance would not be a confounding factor. The Subject also had not consumed any other substances besides a single experience with 6-APB a week or two before the experiment, which had no lasting effects.


Prior to ingestion, the Subject’s stomach contents were near empty, having eaten a carb- and starch-heavy meal (omelet and potatoes) about 4 hours prior, which had been digested normally.


Tolerance and Potential Experimental Confounds


There was no significant tolerance to serotonergic psychedelics, as evidenced by the Subject’s logs and the extended period since last use. Additionally, the Subject had not consumed any hallucinogens or other substances during the preceding weeks, ensuring that the current experience would be unaffected by previous exposure. Her preparation and awareness of possible confounding factors, such as dietary intake and previous substance use, helped maintain a controlled and reliable experience.


4. Timeline of the Experience


Initial Effects


  • 12:37 PM: The Subject ingested 36 mg of 4-AcO-DiPT.
  • 12:55 PM: The first subtle sensations of warmth developed in the chest area.
  • 1:00 PM: The Subject begins to notice mild weightlessness and a sense of energy in the lungs.
  • 1:04 PM: Mild "forced rhythmic breathing" begins, accompanied by a paradoxical restlessness in the legs.
  • 1:13 PM: Physical sensations intensify, with minor enhancements to visual acuity and color perception. No significant visual effects are noted at this stage.
  • 1:28 PM: The Subject observes that no closed-eye visuals (CEVs) or significant visual alterations have emerged, which is atypical for a substituted tryptamine at this dose range.


Physical Sensations and Sedation


  • 1:32 PM: The Subject notes that, despite the lack of visual effects, the experience might be conducive to meditation due to the bodily presence and lack of cognitive impairment.
  • 1:40 PM: Forced rhythmic breathing becomes more pronounced, and tactile sensations are enhanced. The Subject feels physically warm but is not concerned.
  • 1:43 PM: After stepping onto the balcony, the Subject observes a slight increase in the brightness of the scenery, but no notable visual effects such as morphing or color-shifting.
  • 1:47 PM: A sense of sedation grows, though accompanied by a restless energy that manifests in the form of frequent pacing. This energy feels natural and not forced.


Peak Effects and Sensory Enhancement


  • 1:52 PM - 1:55 PM: Euphoria intensifies, accompanied by oversized yawns and pleasurable sighs. Despite this, the Subject does not experience tears, a phenomenon typically seen at higher doses.
  • 2:04 PM: Music appreciation is heightened, as the Subject listens to a favorite electronic playlist while feeling pleasantly sedated and relaxed. The effects of 4-AcO-DiPT seem to be enhancing the enjoyment of the rhythm.
  • 2:10 PM - 2:15 PM: While lying in bed, the Subject feels euphoric and reports the sensation of her body melting into the bed, indicating strong physical relaxation.
  • 2:20 PM: Waves of euphoric energy spread through the body, with the Subject feeling deeply relaxed yet simultaneously awake and sensitive to touch.
  • 2:30 PM: Despite the sedation, the Subject notes alternating states of serene stillness and energetic restlessness, where the need to remain in bed becomes evident.
  • 2:35 PM - 2:45 PM: The Subject describes the experience as "very sexy" at this point. The physical sensations begin to overwhelm the sensory perception, and the focus shifts to tactile and sensual experiences rather than cognitive or visual effects. The Subject performs a quick CEV check and notes only faint visuals, but no full-blown psychedelic imagery or significant tactile enhancement.


Continued Sensory Enhancement


  • 3:05 PM: The Subject feels the peak effects starting to plateau, though she remains uncertain about the trajectory of the experience.
  • 3:15 PM: At this point, the peak has solidified. The Subject experiences mild visual effects, such as drifting, breathing, and morphing of her environment, but there is no intricate patterning or complex geometry.
  • 3:25 PM - 3:30 PM: The Subject enjoys a heightened sense of rhythm and fluidity while dancing, a natural result of the stimulating effects now becoming more prominent. There is a balance between sedation and stimulation that enhances the enjoyment of movement.
  • 3:30 PM: Time distortion becomes more apparent, and the Subject experiences a stronger sense of stimulation during physical activity, balanced with deep relaxation when seated. The Subject notes that this compound is ideal for dancing and social interactions, emphasizing the "sexy" and euphoric nature of the experience.


5. Conclusion


The 4-AcO-DiPT experience proved to be deeply sensual and energetic, with an emphasis on physical sensations over cognitive or visual effects. The Subject's experience was marked by a heightened sensitivity to touch, a unique and pleasant state of sedation, and an overall sense of euphoria. Despite the initial lack of significant visual effects, the compound proved to be a powerful tool for body-centered exploration, especially for those seeking a more embodied and sensual psychedelic experience. The Subject concluded that this substance could be an excellent addition to a "top-shelf" psychedelic kit, particularly for those interested in music, dance, and physical sensations.